Citrage

France
Créteil, Île-de-France, France

Company profile

Citrage company profile

Citrage is a research and development company in the field of health nutrition. In partnership with Paris Descartes University, Citrage develops dietary supplements and oral nutritional supplements for people over 50 years old. The two main products are 100% L-Citrulline, a nonprotein amino acid that has a direct effect on muscle protein synthesis, optimizing the use of other amino acids and improving muscle maintenance. MyoCIT is a dietary supplement to preserve muscle capital during aging. It is intended for young seniors in the prevention of age-related muscle wasting (causing loss of tone, dynamism, increased fatigue) and to those wishing to remain active, to preserve their quality of life. ProteoCIT is an ADDFMS for use in frail elderly people for the prevention or treatment of undernutrition and sarcopenia. In other words, Citrage helps preserve autonomy and quality of life.

Business identity

Contact email
[email protected]
Phone number
+33 9 81 15 47 56
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2009-04-01

Headquarters

Country code
FR
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
1
Last funding
Grant / $54,327 / 2016-03-01
Investors
1
Lead investors
1
Founders
4

Founders and investors

Founders

Cécile LoïChristophe MoinardJean Pascal De BandtLuc Cynober

Lead investors

EISMEA

Investors

EISMEA